Validation of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV

被引:0
|
作者
Yanavich, C. [1 ,2 ]
Pacheco, A. [3 ]
Cardoso, S. [1 ]
Nunes, E. [1 ]
Chaves, U. [1 ]
Santos, R. [1 ]
Morata, M. [1 ]
Veloso, V. G. [1 ]
Grinsztejn, B. [1 ]
Perazzo, H. [1 ]
机构
[1] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] Fundacao Oswaldo Cruz, PROCC, Rio De Janeiro, Brazil
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MOAB0203
引用
收藏
页码:5 / 6
页数:2
相关论文
共 50 条
  • [1] Diagnostic value of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV
    Yanavich, C.
    Pacheco, A. G.
    Cardoso, S. W.
    Nunes, E. P.
    Chaves, Usb
    Freitas, G.
    Santos, R.
    Morata, M.
    Veloso, V. G.
    Grinsztejn, B.
    Perazzo, H.
    [J]. HIV MEDICINE, 2021, 22 (06) : 445 - 456
  • [2] Liver fibrosis by transient elastography in HIV patients with non-alcoholic fatty liver disease (NAFLD)
    Schiavini, M.
    Meraviglia, P.
    Minisci, D.
    Ortu, M.
    Carenzi, L.
    Pocaterra, D.
    Ricci, E.
    Bonfanti, P.
    [J]. ANTIVIRAL THERAPY, 2009, 14 (07) : A59 - A59
  • [3] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    [J]. LABORATORY INVESTIGATION, 2003, 83 (01) : 283A - 283A
  • [4] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 283A - 283A
  • [5] Clinical predictors of advanced fibrosis in patient with non-alcoholic fatty liver disease (NAFLD)
    Siua, W.
    Andiganib, M.
    Frasera, A.
    Vijayana, B.
    Mclemana, L.
    Englisha, S.
    Mukhopadhyaa, A.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 187 - 187
  • [6] Validation of the "NAFLD fibrosis score" in predicting advanced fibrosis in patients with histologically proven non-alcoholic fatty liver disease
    Kang, Hellan
    Omo, Jason
    Joel, Greenson
    Lok, Anna S.
    Conjeevaram, Hari S.
    [J]. HEPATOLOGY, 2007, 46 (04) : 750A - 750A
  • [7] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Jürgen Kurt Rockstroh
    [J]. Current HIV/AIDS Reports, 2017, 14 : 47 - 53
  • [8] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Rockstroh, Juergen Kurt
    [J]. CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53
  • [9] Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
    Gallego-Duran, Rocio
    Cerro-Salido, Pablo
    Gomez-Gonzalez, Emilio
    Jesus Pareja, Maria
    Ampuero, Javier
    Carmen Rico, Maria
    Aznar, Rafael
    Vilar-Gomez, Eduardo
    Bugianesi, Elisabetta
    Crespo, Javier
    Jose Gonzalez-Sanchez, Francisco
    Aparcero, Reyes
    Moreno, Inmaculada
    Soto, Susana
    Teresa Arias-Loste, Maria
    Abad, Javier
    Ranchal, Isidora
    Jesus Andrade, Raul
    Luis Calleja, Jose
    Pastrana, Miguel
    Lo Iacono, Oreste
    Romero-Gomez, Manuel
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [10] Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
    Rocío Gallego-Durán
    Pablo Cerro-Salido
    Emilio Gomez-Gonzalez
    María Jesús Pareja
    Javier Ampuero
    María Carmen Rico
    Rafael Aznar
    Eduardo Vilar-Gomez
    Elisabetta Bugianesi
    Javier Crespo
    Francisco José González-Sánchez
    Reyes Aparcero
    Inmaculada Moreno
    Susana Soto
    María Teresa Arias-Loste
    Javier Abad
    Isidora Ranchal
    Raúl Jesús Andrade
    Jose Luis Calleja
    Miguel Pastrana
    Oreste Lo Iacono
    Manuel Romero-Gómez
    [J]. Scientific Reports, 6